In this episode of Joint Venture with Michael Parker, Our host discusses insuring cannabis related businesses, compliance with the federal banking system, and California Treasurer John Chiang’s strategy to construct a state bank with Cannabis Insurance Specialist and Radio Host Barbara Southworth
Tune In To New Episodes of Joint Venture with Michael Parker Tuesdays, Exclusively on Cashcroptoday.com
CashCropToday Media is a global media, branding and technology company, with a focus on news and information about investing, technology, entrepreneurship, and the lifestyle of Cannabis & Hemp.
Reaching more than 1.2 million people worldwide, CashCropToday offers news coverage focused on Investing in Cannabis & Hemp through public traded companies, political opinions, and documentary programming, 7 days a week.
In this episode Michael Parker discusses insuring cannabis businesses, compliance with the federal banking system, and California Treasurer John Chiang’s strategy to construct a state bank with Cannabis Insurance Specialist and radio host Barbara Southworth.
» Subscribe to CashCropToday: https://www.youtube.com/CashCroptoday
Connect with CashCropToday
Find us on Facebook: https://www.facebook.com/cashcroptoday
Follow us on Twitter: https://twitter.com/cashcroptoday
Follow us on Instagram: https://www.instagram.com/cashcroptoday
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…